Protalix BioTherapeutics, Inc. Contracts & Agreements

71 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Protalix BioTherapeutics, Inc. 2006 Stock Incentive Plan, as amended
Bonus & Incentive Agreements
Protalix BioTherapeutics, Inc.
2024
Description of Capital Stock
Stock Agreements
Protalix BioTherapeutics, Inc.
2024
Amended and Restated Pro BioTherapeutics, Inc. 2006 Stock Incentive Plan, as amended
Bonus & Incentive Agreements
Protalix BioTherapeutics, Inc.
2023
Description of Capital Stock
Stock Agreements
Protalix BioTherapeutics, Inc.
2023
At the Market Offering Agreement, dated February 27, 2023, between the Company and H.C. Wainwright & Co., LLC
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2023
Fill/Finish Agreement effective on August 29, 2022 made by and between Chiesi Farmaceutici S.p.A and Protalix Ltd
Protalix BioTherapeutics, Inc.
2022
Letter Agreement dated August 29, 2022 from Chiesi Farmaceutici S.p.A to Protalix Ltd
Protalix BioTherapeutics, Inc.
Biotechnology
2022
Letter Amendment dated May 2, 2022
Protalix BioTherapeutics, Inc.
Biotechnology
2022
Third Supplemental Indenture, dated as of August 24, 2021, by and among Protalix BioTherapeutics, Inc., the guarantors party hereto and The Bank of New York Mellon Trust Company,...
Indenture Agreements
Protalix BioTherapeutics, Inc.
2021
Form of Exchange Agreement, dated as of August 12, 2021 among Protalix BioTherapeutics, Inc. and the Existing Holders
Exchange Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2021
At the Market Offering Agreement, dated July 2, 2021, between the Company and H.C. Wainwright & Co., LLC
Protalix BioTherapeutics, Inc.
2021
Amended and Restated Agreement between Protalix Ltd. and Comercio e Servios Ltda. dated June 17, 2013
Protalix BioTherapeutics, Inc.
2021
Technology Transfer and Supply Agreement made as of June 18, 2013 by and between Protalix Ltd. and Fundao Oswaldo Cruz
Supply Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
2021
Binding Term Sheet between Protalix Ltd. and Chiesi Farmaceutici S.p.A
Term Sheets
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2021
Underwriting Agreement, dated February 11, 2021, between the Company and BofA Securities, Inc
Underwriting Agreements
Protalix BioTherapeutics, Inc.
2021
ATM Equity OfferingSM Sales Agreement, dated October 1, 2020, between the Company and BofA Securities, Inc
Sales Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2020
Form of Stock Option Agreement (Executives)
Stock Agreements
Protalix BioTherapeutics, Inc.
2020
Form of Stock Option Agreement (Standard)
Stock Agreements
Protalix BioTherapeutics, Inc.
2020
Amended & Restated Protalix BioTherapeutics, Inc. 2006 Employee Stock Incentive Plan, as amended
Bonus & Incentive Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
2020
Employment Agreement with Yael Hayon, Ph.D., dated June 7, 2020
Employment Agreements
Protalix BioTherapeutics, Inc.
2020
Amended and Restated Employment Agreement with Einat Brill Almon, Ph.D., dated June 7, 2020
Employment Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
2020
Description of Capital Stock
Stock Agreements
Protalix BioTherapeutics, Inc.
2020
Form of Warrant
Warrant Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2020
Form of Securities Purchase Agreement
Purchase Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2020
Employment Agreement dated July 28, 2019
Employment Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
2019
Employment Agreement dated May 20, 2019
Employment Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
2019
Exclusive U.S. License and Supply Agreement dated as of July 23, 2018, made by and between Protalix Ltd. and Chiesi Farmaceutici S.p.A
License Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2018
Exclusive License and Supply Agreement dated as of October 17, 2017, made by and between Protalix Ltd. and Chiesi Farmaceutici S.p.A
License Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2018
Second Supplemental Indenture, dated as of November 27, 2017, by and among Protalix BioTherapeutics, Inc., the guarantors party hereto and The Bank of New York Mellon Trust...
Indenture Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2017
Protalix BioTherapeutics, Inc. (Company) The Bank of New York Mellon Trust Company, N.A.,as Trustee (Trustee) 4.50% Convertible Senior Notes due 2022 INDENTURE Dated as of July...
Indenture Agreements
Protalix BioTherapeutics, Inc.
2017
FIRST SupplementalIndenture between PROTALIXBIOTHERAPEUTICS, INC., as Issuer, ANDEACH OF THE GUARANTORS PARTY HERETO, and TheBank of New York Mellon Trust CoMPANY, N.A., as...
Indenture Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2017
FORM OF FACE OF NOTE
Note Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
2017
NOTE PURCHASE AGREEMENT
Note Agreements
Protalix BioTherapeutics, Inc.
2017
EXCHANGE AGREEMENT by and among Protalix BioTherapeutics, Inc. and the Parties Signatory Hereto Dated as of July 24, 2017
Exchange Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2017
PROTALIX BIOTHERAPEUTICS, INC. AS ISSUER AND EACH OF THE GUARANTORS PARTY HERETO 7.50% SENIOR SECURED CONVERTIBLE NOTESDUE 2021 INDENTURE DATED AS OF DECEMBER 7, 2016 THE BANK OF...
Indenture Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2016
Principal Amount $22,500,000 as revised by the Schedule of Increases and Decreases of Global Note attached hereto Protalix BioTherapeutics, Inc. 7.50% Senior Secured Convertible...
Note Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2016
Principal Amount $40,186,000 as revised by the Schedule of Increases and Decreases of Global Note attached hereto Protalix BioTherapeutics, Inc. 7.50% Senior Secured Convertible...
Note Agreements
Protalix BioTherapeutics, Inc.
2016
FORM OF NOTE PURCHASE AGREEMENT
Note Agreements
Protalix BioTherapeutics, Inc.
2016
FORM OF EXCHANGE AGREEMENT by and among Protalix BioTherapeutics, Inc. and the Parties Signatory Hereto Dated as of December 1, 2016
Exchange Agreements
Protalix BioTherapeutics, Inc.
2016
FORM OF SECURITY AGREEMENT dated as of December 7, 2016 among PROTALIX BIOTHERAPEUTICS, INC. THE GUARANTORS PARTY HERETO and WILMINGTON SAVINGS FUND SOCIETY, FSB, as Collateral...
Security Agreements
Protalix BioTherapeutics, Inc.
2016
Dated 7 December 2016 BETWEEN PROTALIX BIOTHERAPEUTICS, INC. as the Company AND ALTSHULER SHAHAM TRUSTS LTD. as Security Trustee FORM OF SECURITY AGREEMENT/DEBENTURE UNLIMITED IN...
Debenture Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2016
AMENDED AND RESTATED EXCLUSIVE LICENSE AND SUPPLY AGREEMENT by and between PFIZER INC. and PROTALIX LTD. October 12, 2015
License Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2015
EMPLOYMENT AGREEMENT
Employment Agreements
Protalix BioTherapeutics, Inc.
2014
AGREEMENT
Protalix BioTherapeutics, Inc.
Biotechnology
2014
Exhibit A
Protalix BioTherapeutics, Inc.
2014
TECHNOLOGYTRANSFER AND SUPPLY AGREEMENT
Supply Agreements
Protalix BioTherapeutics, Inc.
2014
ProtalixBioTherapeutics, Inc. (Company) The Bankof New York Mellon Trust Company, N.A. (Trustee) 4.50%Convertible Senior Notes due 2018 INDENTURE Datedas of September 18, 2013
Indenture Agreements
Protalix BioTherapeutics, Inc.
2013
[FACE OF NOTE]
Note Agreements
Protalix BioTherapeutics, Inc.
2013
ProtalixBioTherapeutics, Inc. $60,000,0004.50% Convertible Notes Due 2018 PurchaseAgreement
Note Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2013
FORM OF RESTRICTED STOCK AGREEMENT/NOTICE PROTALIX BIOTHERAPEUTICS, INC. 2006 STOCK INCENTIVE PLAN, AS AMENDED NOTICE OF RESTRICTED STOCK AWARD
Bonus & Incentive Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
FL
2012
Protalix BioTherapeutics, Inc. 4,500,000 Shares Common Stock ($0.001 par value) Underwriting Agreement
Underwriting Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2012
Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics, Inc.
2011
EMPLOYMENT AGREEMENT
Employment Agreements
Protalix BioTherapeutics, Inc.
2009
UNPROTECTED LEASE Executed and signed in Tel-Aviv on January 13, 2008
Lease Agreements
Protalix BioTherapeutics, Inc.
2008
RESEARCH AND LICENSE AGREEMENT
License Agreements
Protalix BioTherapeutics, Inc.
2007
Underwriting Agreement
Underwriting Agreements
Protalix BioTherapeutics, Inc.
2007
LICENSE AGREEMENT
License Agreements
Protalix BioTherapeutics, Inc.
2007
RESEARCH AND LICENCE AGREEMENT
Protalix BioTherapeutics, Inc.
2007
AGREEMENT made and signed on this 14 day of September, 2006
Protalix BioTherapeutics, Inc.
2007
SCIENTIFICADVISORY BOARD AGREEMENT
Protalix BioTherapeutics, Inc.
2007
EX-4.1 Form of Warrant
Warrant Agreements
Protalix BioTherapeutics, Inc.
2007
EX-10.1 2006 Stock Incentive Plan
Bonus & Incentive Agreements
Protalix BioTherapeutics, Inc.
2007
EX-10.2 Employment Agreement w/Yoseph Shaaltiel
Employment Agreements
Protalix BioTherapeutics, Inc.
2007
EX-10.3 Employment Agreement w/Einat Almon
Employment Agreements
Protalix BioTherapeutics, Inc.
2007
EX-10.4 Employment Agreement w/David Aviezer
Employment Agreements
Protalix BioTherapeutics, Inc.
2007
EX-10.5 Employment Agreement w/Yossi Maimon
Employment Agreements
Protalix BioTherapeutics, Inc.
2007
EX-10.6 License Agreement
License Agreements
Protalix BioTherapeutics, Inc.
2007
EX-10.7 Research and License Agreement
License Agreements
Protalix BioTherapeutics, Inc.
2007
EX-10.8 Agreement between Teva and Protalix
Protalix BioTherapeutics, Inc.
2007
EX-10-9 Unprotected Lease Contract
Lease Agreements
Protalix BioTherapeutics, Inc.
2007
EX-10.10 Merger Agreement and Plan
Merger Agreements
Protalix BioTherapeutics, Inc.
2007